VARUN M

488 posts

VARUN M banner
VARUN M

VARUN M

@varunnephro

Clinical Fellow | Salford Royal NHS | @SRIHER_Official Alumnus l @NSMCInternship Co 2021 l @ISB_Healthcare APMH Co 2022

Manchester, England Katılım Nisan 2016
997 Takip Edilen969 Takipçiler
Sabitlenmiş Tweet
VARUN M
VARUN M@varunnephro·
“Silicon isn’t just for computers. It can make a pretty good kidney, too” @WIRED #NephMadness 💪 contender in the #ArtificialKidney region 💥The device incorporated with silicon nanotechnology & tissue engineering - Let’s talk about The Implantable Bioartificial Kidney #NSMC
VARUN M tweet media
English
2
30
44
0
VARUN M retweetledi
Wisit Cheungpasitporn MD FACP | FASN | FAST
I have been drafting my dream AI-powered nephrology outpatient clinical workflow 🩺📈 and would love to share my thoughts 😊🤔 Discussion more on @ASNKidney AI forum community.asn-online.org/discussion/ai-… As shown in the table, AI tools support each phase of the outpatient nephrology workflow: Pre-visit, AI synthesizes EHR data 📋🤖 to highlight recent hospitalizations, medication changes, and abnormal labs. Risk models 🚩 prioritize high-acuity patients, while NLP triage identifies urgent referral reasons—ensuring a focused visit. During the visit 🧑‍⚕️👩‍⚕️, ambient scribes and NLP tools 📝 reduce clerical burden, enhancing patient interaction. Decision-support systems integrate real-time data to guide evidence-based care 💊🧬, flag care gaps, and suggest personalized plans 📚✅. Post-visit, AI monitors results and messages 📲🔁, triggering alerts for clinical deterioration. Home monitoring and AI inbox triage improve follow-up, reduce delays, and minimize unnecessary visits 🌐❤️‍🩹. @MayoClinicNeph
Wisit Cheungpasitporn MD FACP | FASN | FAST tweet media
English
4
23
51
2.9K
VARUN M retweetledi
Nephrology Journal Club
1/10 Last #NephJC we discussed the combination therapy of empagliflozin and finerenone 💊 #TenPostNephJC 🌵From a therapeutic dessert to a flood of options in DKD - what is the best timing to keep the kidneys afloat
Nephrology Journal Club tweet media
English
2
13
51
6.7K
VARUN M retweetledi
NDT
NDT@NDTsocial·
GLP-1-based therapeutics for cardiorenal protection in metabolic diseases 🆓doi.org/10.1093/ndt/gf…
NDT tweet mediaNDT tweet mediaNDT tweet mediaNDT tweet media
English
1
24
79
5K
VARUN M retweetledi
ERA - European Renal Association
First in Novel CKD Treatments Beyond the Pillars (room K), Jonathan Barratt presenting 🥁Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart Zigakibart= humanized MAb that blocks APRIL, a soluble factor whose blood level is elevated in patients with IgAN. #era25 6/
ERA - European Renal Association tweet media
English
2
15
35
3.2K
VARUN M retweetledi
ERA - European Renal Association
💥 Game Changers in CKD and T2DM 💥 first up Peter Rossing on GLP1s ▶️Early CV studies suggested kidney benefits of GLP1s ▶️Flow trial designed to look at kidney outcomes in DKD 💥 Showed improvement in composite kidney outcomes, eGFR slope, cardiovascular outcomes and all cause mortality. 💥💥 NNT only 20 for composite kidney outcomes when treated for 3 years 💥 Outcomes similar if already on SGLT2 (15%)or on MRA ( 7%) -▶️ benefits additive! 💥More to come- tirzepatide also showing big effects and more trials on the way 💥💥Exciting times! 💥💥 - Sarah Gleeson
ERA - European Renal Association tweet mediaERA - European Renal Association tweet mediaERA - European Renal Association tweet mediaERA - European Renal Association tweet media
English
3
12
48
3K
VARUN M retweetledi
ERA - European Renal Association
#ERA25 #BeyondNephrology 1/And now one of the most awaited sessions in Late Breaking Clinical Trials 1: Cutting-Edge Clinical Trials in #Nephrology🥁 🚨 THE CONFIDENCE TRIAL: EFFICACY/SAFETY OF COMBINING FINERENONE WITH EMPAGLIFLOZIN IN PEOPLE WITH CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES 👤Rajiv Agarwal ✖️@AgarwalRajivMD 👤 Peter Rossing ✖️@P_Rossing 👤 Hiddo J.L. Heerspink ✖️@HeerspinkHiddo 👤 Johannes F.E. Mann
ERA - European Renal Association tweet media
English
3
28
71
8.6K
VARUN M retweetledi
NEJM
NEJM@NEJM·
Presented at #ERA25: In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk @ERAkidney
NEJM tweet media
English
4
134
297
73.7K
VARUN M retweetledi
AINU Nephrology
AINU Nephrology@AinuNephrology·
@AINUKidneyRun "Optimising prescription practises" This #WorldKidneyDay AINU team promotes best prescription practises for optimal outcomes.. Creating awareness by annual running event..
AINU Nephrology tweet mediaAINU Nephrology tweet mediaAINU Nephrology tweet mediaAINU Nephrology tweet media
English
0
2
11
287